Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · USANA HEALTH SCIENCES INC (USNA)

USANA swings to $21.4 million Q2 net loss and cuts 2026 guidance

Negative Impact 4 of 5 earnings Written later

USANA Health Sciences reported second-quarter 2026 net sales of $223 million, down from $236 million a year earlier, and a net loss attributable to the company of $21.4 million, compared with net earnings of $9.7 million. The loss includes an estimated preliminary non-cash impairment charge of $29.1 million tied to Hiya, and the company lowered its fiscal 2026 outlook, now projecting a full-year net loss of $11 million versus its prior expectation of net earnings of $20 million to $27 million.

Key points

  • Q2 2026 diluted EPS was $(1.16) versus $0.52; adjusted diluted EPS was $(0.07) versus $0.74.
  • Hiya net sales were $28 million, down 17% year over year, and Rise Wellness net sales were $3 million, up 40%.
  • Fiscal 2026 guidance: consolidated net sales of $910 million (previously $925 million to $1.0 billion) and adjusted EBITDA of $87 million (previously $101 million to $109 million).
  • The company ended the quarter with $169 million in cash and zero debt and reported $20 million in free cash flow.

The filing

CompanyUSANA HEALTH SCIENCES INC (USNA)
Form8-K, current report
Filed with the SECAug 4, 2026, 4:22 PM ET
Accession number0000896264-26-000050

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.